[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.50.247. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
July 2006

Open-Label Extension Studies and Misinformation—Reply

Arch Neurol. 2006;63(7):1036-1037. doi:10.1001/archneur.63.7.1036-b

In reply

We thank Dr Schneider for his comments on our report.1 We share his enthusiasm for “well-conducted and methodologically sound randomized controlled trials.”2 However, we do not agree that “as physicians, we should be comfortable prescribing medication for longer periods of time than the length of the randomized trials” based on the evidence from the shorter-term randomized trials and “patients' preferences.” We believe that this prescribing comfort should be informed, to the extent possible, by the best available evidence.

First Page Preview View Large
First page PDF preview
First page PDF preview
×